Emerging countries are experiencing continuous population growth that has quickly outpaced the quality of their stagnant healthcare delivery infrastructures. The so-called BRICS countries (Brazil, Russia, India, China, and South Africa) are the most rapidly developing...
Unlike other industries, drug companies cannot decide to place their products on the market alone. A national agency makes the final decision and must also approve the selling price. This price does reflect not only the perceived value for the end user but also the...
Data collection techniques have been quickly evolving in the new digital landscape, leading to sweeping changes in the upstream marketing process as well. In the past, pharmaceutical companies came to marketing agencies with a precise question; it was up to the...
First discovered in the Democratic Republic of the Congo in 1959, HIV is now thought to have already been the cause of several deaths dating back to the 1930s. It wasn’t until the 1980s that the illness began to rapidly develop, resulting in the current epidemic. A...
Between 2014 and 2018, annual growth in the healthcare market will be 4 to 7 percent, and will reach the US$ 1 trillion mark by 2018. Considering the growing populations in emerging countries and their increasing healthcare needs, IMS expects the market to climb to...
La population mondiale croit sans décéléré depuis plusieurs décennies accompagnant un vieillissement posant de sérieux problèmes concernant les systèmes de santé en place. Les places d’hôpital se font chères, souvent accompagnées d’une longue attente en amont avant...
